These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 1966028

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The prognostic value of serum neuron specific enolase detection in small cell lung cancer].
    Jin B, Zhao L, Zhou C.
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Dec; 24(12):722-4. PubMed ID: 11930699
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment monitoring of patients with small cell lung cancer by determining levels of serum neuron specific enolase].
    Jassem E.
    Pneumonol Alergol Pol; 1993 Dec; 61(1-2):56-60. PubMed ID: 8388760
    [Abstract] [Full Text] [Related]

  • 6. [Determination of serum neuron-specific enolase in bronchial tumors of neuroendocrine origin].
    Rapellino M, Pecchio F, Cunazza M, Baldi S, Adamo MR, Casadio C, Faga C, Baldi C, Oliaro A, Albertino B.
    Minerva Med; 1988 Dec; 79(12):1051-2. PubMed ID: 2850512
    [Abstract] [Full Text] [Related]

  • 7. Significance of serum neuron-specific enolase as a predictor of relapse of small cell lung cancer.
    Nitta T, Fukuoka M, Masuda N, Kusunoki Y, Matsui K, Kudoh S, Hirashima T, Yana T, Ito K, Takada M.
    Jpn J Clin Oncol; 1995 Oct; 25(5):179-83. PubMed ID: 7474404
    [Abstract] [Full Text] [Related]

  • 8. Neuron specific enolase: a marker of (small cell) cancers of neuronal and neuroendocrine origin.
    Cooper EH.
    Biomed Pharmacother; 1985 Oct; 39(4):165-6. PubMed ID: 2998499
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
    Aroney RS, Dermody WC, Aldenderfer P, Parsons P, McNitt K, Marangos PJ, Whitacre MY, Ruddon RW, Wiernik PH, Aisner J.
    Cancer Treat Rep; 1984 Jun; 68(6):859-66. PubMed ID: 6329508
    [Abstract] [Full Text] [Related]

  • 12. [Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma].
    Lorenz J, Gillmann-Blum D, Jensen M, Kreienberg R.
    Pneumologie; 1990 Nov; 44(11):1259-63. PubMed ID: 2177891
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer.
    Spinazzi A, Soresi E, Boffi R, Nonis A, Noseda A, Cobelli S, Scanni A.
    Cancer Detect Prev; 1994 Nov; 18(3):209-20. PubMed ID: 8076383
    [Abstract] [Full Text] [Related]

  • 15. [The changes in serum neuron-specific enolase in patients with small cell lung cancer].
    Taitou H, Sakurai M, Tamura T, Sasaki Y, Eguchi K, Shinkai T, Ookura H, Saijo N.
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3046-9. PubMed ID: 2823722
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
    Wójcik E, Kulpa JK, Sas-Korczyńska B, Korzeniowski S, Jakubowicz J.
    Anticancer Res; 2008 Nov; 28(5B):3027-33. PubMed ID: 19031951
    [Abstract] [Full Text] [Related]

  • 20. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
    Ando S, Suzuki M, Yamamoto N, Iida T, Kimura H.
    Anticancer Res; 2004 Nov; 24(3b):1941-6. PubMed ID: 15274381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.